Astellas Looks To Transplant Drugs To Make It Leading Indian Drug Maker
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma's intended focus on the field of organ transplantation to the point of being an industry leader plays a key role in the firm's Indian unit's plan to be a specialist drug maker in India